Items where authors include "Gladman, DD"

Export as [feed] Atom [feed] RSS
Number of items: 45.

Article

Gladman, DD, Mease, PJ, Bird, P et al. (14 more authors) (2022) Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial. Trials, 23 (1). 743. ISSN 1745-6215

Coates, LC, Soriano, ER, Corp, N et al. (42 more authors) (2022) Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021. Nature Reviews Rheumatology, 18 (8). pp. 465-479. ISSN 1759-4790

Mease, PJ, Helliwell, PS orcid.org/0000-0002-4155-9105, Gladman, DD et al. (14 more authors) (2021) Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies. The Lancet Rheumatology, 3 (10). e715-e723. ISSN 2665-9913

Coates, LC, Baraliakos, X, Blanco, FJ et al. (17 more authors) (2021) The phenotype of axial spondyloarthritis: is it dependent on HLA‐B27 status? Arthritis Care & Research, 73 (6). pp. 856-860. ISSN 2151-464X

Coates, LC, Merola, JF, Mease, PJ et al. (10 more authors) (2020) Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis. Rheumatology. keaa271. ISSN 1462-0324

Mease, PJ, Gladman, DD, Deodhar, A et al. (9 more authors) (2020) Impact of guselkumab, an interleukin-23 p19 subunit inhibitor, on enthesitis and dactylitis in patients with moderate to severe psoriatic arthritis: results from a randomised, placebo-controlled, phase II study. RMD Open, 6 (2). e001217. ISSN 2056-5933

De Marco, G orcid.org/0000-0003-2406-161X, Berekméri, A, Coates, LC et al. (12 more authors) (2020) Systematic literature review of non-topical treatments for early, untreated (systemic therapy naïve) psoriatic disease: a GRAPPA initiative. Rheumatology Advances in Practice. ISSN 2514-1775

Goel, N, Coates, LC orcid.org/0000-0002-4756-663X, De Marco, G orcid.org/0000-0003-2406-161X et al. (11 more authors) (2020) GRAPPA 2019 Project Report. The Journal of Rheumatology Supplement, 96. pp. 53-57. ISSN 0380-0903

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus. Arthritis and Rheumatology, 71 (9). pp. 1400-1412. ISSN 2326-5191

Aringer, M, Costenbader, K, Daikh, D et al. (61 more authors) (2019) 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases, 78 (9). pp. 1151-1159. ISSN 0003-4967

Mease, PJ, Gladman, DD, Collier, DH et al. (5 more authors) (2019) Etanercept and Methotrexate as Monotherapy or in Combination for Psoriatic Arthritis: Primary Results From a Randomized, Controlled Phase III Trial. Arthritis & Rheumatology, 71 (7). pp. 1112-1124. ISSN 2326-5191

Helliwell, PS, Favier, G, Gladman, DD et al. (6 more authors) (2019) Best-practice Indicators in Psoriatic Disease Care. The Journal of Rheumatology Supplement, 95. pp. 38-45. ISSN 0380-0903

Goel, N, FitzGerald, O, Gladman, DD et al. (6 more authors) (2019) GRAPPA 2018 Project Report. The Journal of Rheumatology Supplement, 95. pp. 54-57. ISSN 0380-0903

Jadon, DR, Chandran, V, Ogdie, A et al. (12 more authors) (2019) Proceedings of the 2018 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology Supplement, 95. pp. 11-19. ISSN 0380-0903

Gladman, DD, Orbai, A-M, Klitz, U et al. (6 more authors) (2019) Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritis. Arthritis Research and Therapy, 21. ARTN 38. ISSN 1478-6354

Mease, P, Coates, LC, Helliwell, PS et al. (14 more authors) (2018) Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial. The Lancet, 392 (10162). pp. 2367-2377. ISSN 0140-6736

Cauli, A, Gladman, DD, Mathieu, A et al. (23 more authors) (2018) Physician’s Global Assessment in Psoriatic Arthritis: A Multicenter GRAPPA Study. The Journal of Rheumatology, 45 (7). 171183. ISSN 0315-162X

Jadon, DR, Chandran, V, Stober, C et al. (9 more authors) (2018) Proceedings of the 2017 GRAPPA Collaborative Research Network Meeting. The Journal of Rheumatology, 94 (S). pp. 54-61. ISSN 0380-0903

Højgaard, P, Klokker, L, Orbai, A-M et al. (17 more authors) (2018) A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative. Seminars in Arthritis and Rheumatism, 47 (5). pp. 654-665. ISSN 0049-0172

Smolen, JS, Schöls, M, Braun, J et al. (34 more authors) (2018) Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force. Annals of the Rheumatic Diseases, 77 (1). pp. 3-17. ISSN 0003-4967

Ibrahim, A, Gladman, DD, Thavaneswaran, A et al. (4 more authors) (2017) Sensitivity and Specificity of Radiographic Scoring Instruments for Detecting Change in Axial Psoriatic Arthritis. Arthritis Care and Research, 69 (11). pp. 1700-1705. ISSN 0893-7524

Favier, G, Gladman, DD, Merola, JF et al. (3 more authors) (2017) Benchmarking Care in Psoriatic Arthritis — The QUANTUM Report: A Report from the GRAPPA 2016 Annual Meeting. The Journal of Rheumatology, 44 (5). pp. 674-678. ISSN 0315-162X

Jadon, DR, Gladman, DD, Mease, PJ et al. (19 more authors) (2017) Proceedings of the GRAPPA 2016 Retreat. The Journal of Rheumatology, 44 (5). pp. 668-673. ISSN 0315-162X

Helliwell, PS, Gladman, DD and Gottlieb, AB (2017) Prologue: 2016 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology, 44 (5). pp. 658-660. ISSN 0315-162X

Mease, PJ, Helliwell, PS, Boehncke, W-H et al. (5 more authors) (2016) GRAPPA 2015 Research and Education Project Reports. The Journal of Rheumatology, 43 (5). pp. 979-985. ISSN 0315-162X

Gladman, DD, Mease, PJ, Boehncke, W-H et al. (2 more authors) (2016) Presidential Round Table: A Report from the GRAPPA Annual Meeting. The Journal of Rheumatology, 43 (5). pp. 986-989. ISSN 0315-162X

Boehncke, W-H, Gladman, DD and Helliwell, PS (2016) Prologue: 2015 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA). The Journal of Rheumatology, 43 (5). pp. 949-951. ISSN 0315-162X

Orbai, A-M, Mease, PJ, de Wit, M et al. (15 more authors) (2016) Report of the GRAPPA-OMERACT Psoriatic Arthritis Working Group from the GRAPPA 2015 Annual Meeting. The Journal of Rheumatology, 43 (5). pp. 965-969. ISSN 0315-162X

Helliwell, PS, FitzGerald, O, Fransen, J et al. (34 more authors) (2013) The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project). Annals of the Rheumatic Diseases, 72 (6). pp. 986-991. ISSN 1468-2060

Conference or Workshop Item

Mease, PJ, Coates, LC, Van den Bosch, F et al. (8 more authors) (2021) Correlation Between Skin Involvement, Joint Involvement and Enthesitis in Patients with Active Psoriatic Arthritis: Post-hoc Analysis of EQUATOR/EQUATOR2. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Helliwell, P orcid.org/0000-0002-4155-9105, Coates, LC, Van den Bosch, F et al. (7 more authors) (2021) The Effect of Filgotinib on Enthesitis: 100-Week Data from an Open-Label Extension Study in Patients with Active Psoriatic Arthritis. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Mease, PJ, Helliwell, P orcid.org/0000-0002-4155-9105 et al. (8 more authors) (2021) Effect of Filgotinib on Pasdas: Drivers of Low and Very Low Activity up to Week 100. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Soriano, E, Corp, N et al. (31 more authors) (2021) The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) Treatment Recommendations 2021. In: EULAR 2021 Virtual Congress (Rheumatology), 02-05 Jun 2021, Virtual.

Coates, LC, Gladman, DD, Van den Bosch, F et al. (10 more authors) (2021) Long-Term Outcomes with Filgotinib, an Oral Preferential Janus Kinase 1 Inhibitor: 100-Week Data from an Open-Label Extension (OLE) Study in Patients with PSA. In: Twelfth International Congress on Spondyloarthritides, 09-11 Sep 2021, Virtual.

Poddubnyy, D, Mease, PJ, Van den Bosch, F et al. (9 more authors) (2020) AB0824 WHICH PARAMETERS ARE RELEVANT IN THE IDENTIFYING AXIAL INVOLVEMENT IN PSORIATIC ARTHRITIS? – RESULTS OF A SURVEY AMONG ASAS AND GRAPPA MEMBERS. In: EULAR 2020, 03-06 Jun 2020, Online.

Gladman, DD, Coates, LC, Van den Bosch, F et al. (9 more authors) (2020) FRI0339 LONG-TERM EFFICACY OF THE ORAL SELECTIVE JANUS KINASE 1 INHIBITOR FILGOTINIB IN PSORIATIC ARTHRITIS: WEEK 52 RESPONSE PATTERNS IN INDIVIDUAL PATIENTS FROM AN OPEN-LABEL EXTENSION (OLE) STUDY (EQUATOR2). In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Van den Bosch, F, Coates, LC et al. (9 more authors) (2020) FRI0343 EFFICACY AND SAFETY OF FILGOTINIB, A SELECTIVE JANUS KINASE 1 INHIBITOR, IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: SUBGROUP ANALYSES FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 2 TRIAL (EQUATOR). In: EULAR 2020, 03-06 Jun 2020, Online.

Husni, ME, Gladman, DD, Helliwell, P et al. (9 more authors) (2020) FRI0344 THE LONG-TERM EFFECT OF TREATING PSORIATIC ARTHRITIS WITH THE JANUS KINASE 1-SELECTIVE INHIBITOR FILGOTINIB ON LIPID PROFILES: AN ANALYSIS OF THE EQUATOR AND EQUATOR2 TRIALS. In: EULAR 2020, 03-06 Jun 2020, Online.

Helliwell, P, Gladman, DD, Poddubnyy, D et al. (13 more authors) (2020) OP0054 EFFICACY OF GUSELKUMAB, A MONOCLONAL ANTIBODY THAT SPECIFICALLY BINDS TO THE P19-SUBUNIT OF IL-23, ON ENDPOINTS RELATED TO AXIAL INVOLVEMENT IN PATIENTS WITH ACTIVE PSA WITH IMAGING-CONFIRMED SACROILIITIS: WEEK-24 RESULTS FROM TWO PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDIES. In: EULAR 2020, 03-06 Jun 2020, Online.

Proceedings Paper

Helliwell, P, Deodhar, A, Gottlieb, AB et al. (7 more authors) (2019) Comparing Composite Measures of Disease Activity in Psoriatic Arthritis: Results From a Randomized Phase 2 Trial with Guselkumab. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 1843.

De Marco, G, Berekméri, A, Coates, LC et al. (10 more authors) (2019) Non Topical Pharmacological Treatment of Early, Untreated (DMARD-Naive, Systematic Therapy-Naive) Psoriatic Disease: a Systematic Review. In: Annals of the Rheumatic Diseases. EULAR 2019: Annual European Congress of Rheumatology, 12-15 Jun 2019, Madrid, Spain. BMJ Publishing Group , p. 904.

Duarte-Garcia, A, Eder, L, Stephens-Shields, A et al. (13 more authors) (2018) Construct Validity of the Swollen and Tender Joint Counts for the Measurement of MSK Disease Activity in Psoriatic Arthritis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Gladman, DD, Boehncke, W-H, Gottlieb, AB et al. (8 more authors) (2018) The Effect of Guselkumab on Dactylitis: Results from a Phase 2 Study in Patients with Active Psoriatic Arthritis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Helliwell, P, Gladman, DD, Chakravarty, SD et al. (5 more authors) (2018) Efficacy of Ustekinumab on Spondylitis-Associated Endpoints in TNF-Naïve Active Psoriatic Arthritis Patients with Physician-Reported Spondylitis. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

Mease, PJ, Gladman, DD, van den Bosch, F et al. (10 more authors) (2018) Filgotinib, an Oral, Selective Janus Kinase 1 Inhibitor, Is Effective in Psoriatic Arthritis Patients with an Inadequate Response to Conventional Disease-Modifying Anti-Rheumatic Drugs: Results from a Randomized, Placebo-Controlled, Phase 2 Study. In: Arthritis and Rheumatology. 2018 ACR/ARHP Annual Meeting, 19-24 Oct 2018, Chicago, IL, USA. Wiley .

This list was generated on Sat Mar 23 18:39:11 2024 GMT.